Christopher Freeman
2021
In 2021, Christopher Freeman earned a total compensation of $5.4M as Chief Commercial Officer at Guardant Health.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $183,938 |
| Option Awards | $2,539,902 |
| Salary | $249,231 |
| Stock Awards | $2,156,323 |
| Other | $7,056 |
| Total | $5,436,449 |
Freeman received $2.5M in option awards, accounting for 47% of the total pay in 2021.
Freeman also received $300K in bonus, $183.9K in non-equity incentive plan, $249.2K in salary, $2.2M in stock awards and $7.1K in other compensation.
Rankings
In 2021, Christopher Freeman's compensation ranked 2,356th out of 12,405 executives tracked by ExecPay. In other words, Freeman earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,356 out of 12,405 | 81st |
Division Services | 635 out of 2,289 | 72nd |
Major group Health Services | 66 out of 252 | 74th |
Industry group Medical And Dental Laboratories | 16 out of 73 | 78th |
Industry Medical Laboratories | 16 out of 73 | 78th |
Source: SEC filing on April 28, 2022.
Freeman's colleagues
We found five more compensation records of executives who worked with Christopher Freeman at Guardant Health in 2021.